Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Total article views   HTML views PDF downloads Totals
10,444 Dovepress* 8,826+ 1,508 10,334
PubMed Central* 1,618 445 2,063
Totals 10,444 1,953 12,397
*Since 3 August 2017

View citations on PubMed Central and Google Scholar